RATES OF SERIOUS INFECTIONS, OPPORTUNISTIC INFECTIONS, INFLAMMATORY BOWEL DISEASE, AND CANCERS IN SUBJECTS RECEIVING ETANERCEPT VERSUS CONTROLS FROM CLINICAL TRIALS IN ANKYLOSING SPONDYLITIS
Author(s):
Heijde, D. van der; Baumgartner, S.; Wajdula, J.; Fletcher, T.; Wishneski, C.; Vlahos, B.; Foehl, J.; Freundlich, B.; Koenig, A.
